Sentinel Lymph Node Biopsy
"Sentinel Lymph Node Biopsy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The SENTINEL LYMPH NODE is the first lymph node to receive drainage from a neoplasm.
Descriptor ID |
D021701
|
MeSH Number(s) |
E01.370.225.500.384.100.580 E01.370.225.998.054.580 E01.370.388.100.580 E04.074.580 E04.446.819 E05.200.500.384.100.580 E05.200.998.054.580 E05.242.384.100.580
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sentinel Lymph Node Biopsy".
Below are MeSH descriptors whose meaning is more specific than "Sentinel Lymph Node Biopsy".
This graph shows the total number of publications written about "Sentinel Lymph Node Biopsy" by people in this website by year, and whether "Sentinel Lymph Node Biopsy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 1 | 2 | 2004 | 0 | 1 | 1 | 2005 | 3 | 0 | 3 | 2006 | 4 | 0 | 4 | 2007 | 2 | 1 | 3 | 2008 | 0 | 2 | 2 | 2009 | 1 | 0 | 1 | 2010 | 2 | 1 | 3 | 2011 | 2 | 1 | 3 | 2012 | 1 | 0 | 1 | 2013 | 2 | 1 | 3 | 2014 | 1 | 1 | 2 | 2016 | 0 | 2 | 2 | 2017 | 1 | 3 | 4 | 2018 | 1 | 1 | 2 | 2019 | 4 | 2 | 6 | 2020 | 1 | 2 | 3 | 2021 | 0 | 2 | 2 | 2022 | 0 | 3 | 3 | 2023 | 0 | 1 | 1 | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Sentinel Lymph Node Biopsy" by people in Profiles.
-
Cucinella G, Schivardi G, Zhou XC, AlHilli M, Wallace S, Wohlmuth C, Baiocchi G, Tokgozoglu N, Raspagliesi F, Buda A, Zanagnolo V, Zapardiel I, Jagasia N, Giuntoli R, Glickman A, Peiretti M, Lanner M, Chacon E, Di Guilmi J, Pereira A, Laas-Faron E, Fishman A, Nitschmann CC, Kurnit K, Moriarty K, Joehlin-Price A, Lees B, Covens A, De Brot L, Taskiran C, Bogani G, Landoni F, Grassi T, Paniga C, Multinu F, De Vitis LA, Hern?ndez A, Mastroyannis S, Ghoniem K, Chiantera V, Shahi M, Fought AJ, McGree M, Mariani A, Glaser G. Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study. Int J Gynecol Cancer. 2024 Feb 05; 34(2):179-187.
-
Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas CV, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, Alvarado MD, Yang RL, Chan TW, Sheade JB, Ahrendt GM, Larson KE, Switalla K, Tuttle TM, Tchou JC, Rao R, Tamirisa N, Singh P, Gould RE, Terando A, Sauder C, Hewitt K, Chiba A, Esserman LJ, Mukhtar RA. Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial. Ann Surg Oncol. 2023 Oct; 30(11):6401-6410.
-
Leonard LD, de Araujo TB, Quinn C, Thomas MB, Beaty L, Mott NM, Colborn K, Heelan AA, Tevis SEA, Christian N, Arhendt G, Gleisner AL. De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5692-5702.
-
Leonard LD, Beaty L, Thomas M, Quinn C, Colborn KL, de Araujo TB, Torphy RJ, Assump??o LR, Olino K, Studts CR, Rodriguez Franco S, McCarter M, Stewart C, Gleisner AL. Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma. J Surg Oncol. 2023 Mar; 127(4):716-726.
-
Teller P, Nguyen TT, Tseng J, Allen L, Matsen CB, Bellavance E, Kaufman D, Hieken T, Nagel S, Patten C, Pomerenke L, Tevis SE, Sarantou T. Innovation in Breast Surgery: Practical and Ethical Considerations. Ann Surg Oncol. 2022 Oct; 29(10):6144-6150.
-
Jarell A, Gastman BR, Dillon LD, Hsueh EC, Podlipnik S, Covington KR, Cook RW, Bailey CN, Quick AP, Martin BJ, Kurley SJ, Goldberg MS, Puig S. Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test. J Am Acad Dermatol. 2022 12; 87(6):1312-1320.
-
Straker RJ, Krupp K, Sharon CE, Thaler AS, Kelly NJ, Chu EY, Elder DE, Xu X, Miura JT, Karakousis GC. Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort. Ann Surg Oncol. 2022 Aug; 29(8):5207-5216.
-
Cost NG, Ehrlich PF. Invited commentary on Sadeghi, et?al.: Sentinel lymph node biopsy in pediatric Wilms tumor. J Pediatr Surg. 2022 08; 57(8):1523-1524.
-
Torphy RJ, Friedman C, Ho F, Leonard LD, Thieu D, Lewis KD, Medina TM, Robinson WA, Gonzalez RC, Stewart CL, Kounalakis N, McCarter MD, Gleisner A. Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection. Ann Surg Oncol. 2022 Feb; 29(2):806-815.
-
Kuijer A, Dominici LS, Rosenberg SM, Hu J, Gelber S, Di Lascio S, Wong JS, Ruddy KJ, Tamimi RM, Schapira L, Borges VF, Come SE, Sprunck-Harrild K, Partridge AH, King TA. Arm Morbidity After Local Therapy for Young Breast Cancer Patients. Ann Surg Oncol. 2021 Oct; 28(11):6071-6082.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|